Sonoma Pharmaceuticals, Inc. (SNOA)

Sonoma Pharmaceuticals Revenue

Sonoma Pharmaceuticals had revenue of $4.01M in the quarter ending June 30, 2025, with 18.40% growth. This brings the company's revenue in the last twelve months to $14.91M, up 17.43% year-over-year. In the fiscal year ending March 31, 2025, Sonoma Pharmaceuticals had annual revenue of $14.29M with 12.19% growth.

• Revenue (ttm): $14.91M
• Revenue Growth: +17.43%
• P/S Ratio: 0.29
• Revenue / Employee: $1,864,000
• Employees: 8
• Market Cap: 5.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	14.29M	1.55M	12.19%
Mar 31, 2024	12.74M	-537.00K	-4.05%
Mar 31, 2023	13.27M	644.00K	5.10%
Mar 31, 2022	12.63M	-6.00M	-32.21%
Mar 31, 2021	18.63M	701.00K	3.91%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.